Fred Alger Management, LLC Maxcyte, Inc. Transaction History
Fred Alger Management, LLC
- $19.7 Billion
- Q4 2024
A detailed history of Fred Alger Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 389,435 shares of MXCT stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
389,435
Previous 389,618
0.05%
Holding current value
$1.41 Million
Previous $1.52 Million
6.93%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$33.8 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$29.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$19.7 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$18.3 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$16 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $368M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...